OpenAI’s GPT-3 Reported as Unviable in Medical Tasks by Healthcare Firm
Description
The French digital care company, Nabla, in researching GPT-3’s capabilities for medical documentation, diagnosis support, and treatment recommendation, found its inconsistency and lack of scientific and medical expertise unviable and risky in healthcare applications. This incident has been downgraded to an issue as it does not meet current ingestion criteria.
Actors
Alleged Deployers
- none
Alleged Developers
- openai
- nabla
Harmed Parties
- nabla-customers
Classification
Risk Domain
AI Safety & FailuresRisk Subdomain
7.3. Lack of capability or robustness
MIT Risk Profile
Topics
Source
Related Incidents (AI Safety & Failures)
View all →Research Papers on This Topic
View all →Concrete Problems in AI Safety
A Survey on Explainable Artificial Intelligence (XAI): Towards Medical XAI
Representation Engineering: A Top-Down Approach to AI Transparency
Explainable artificial intelligence (XAI) in deep learning-based medical image analysis
Mitigation Tools
Tools related to this risk domain, via shared responsible AI topics.